Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Insurance Coverage Learn why insurance does not currently cover Retatrutide as an approved prescription and how coverage could be evaluated after possible future regulatory approval
Shift could reflect a changing demand away from oncology toward addressing metabolic disorders GLP1 agonist drugs transformed the weight loss and diabetes landscape in 2023, propelled by robust clinical trial results and a surge in endorsements from celebrities and influencers
This section reflects publicly available FDA information as of June 2026
Physician Consultation: Noom members are evaluated by board-certified obesity experts before qualifying for the program
.png.jpg)
US$ 22.43
US$ 27.57
US$ 27.21
US$ 21.25
US$ 20.52
US$ 22.82
